SYNTHETIC ALPHA MELANOCYTE STIMULATING HORMONE
Référence MBS230189-0,5mg
Conditionnement : 0.5mg
Marque : MyBiosource
Synthetic ALPHA Melanocyte Stimulating HORMONE Peptide – Synthetic Peptide, HPLC: >95% Purity
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS230189Synthetic alpha-melanocyte stimulating hormonePeptide sequence: Ac-SYSMEHFRWGKPV-NH2Alpha-MSH is a peptide hormone produced in the anterior pituitary gland involved in melanin production and deposition. It is also associated with the actions and production of… More details
Product Overview
Online Datasheet in PDFProduct Name
ALPHA MELANOCYTE STIMULATING HORMONE (POMC), Peptide
Full Product Name
SYNTHETIC ALPHA MELANOCYTE STIMULATING HORMONE
Product Gene Name
POMC peptide
Product Synonym Names
ALPHA MSH
Form/Format
Purified
Purified synthetic peptide - liquid
Purified synthetic peptide - liquid
Purity/Purification
HPLC: >95%
Concentration
Total protein concentration 1 mg/ml (lot specific)
Preparation and Storage
Store at -20 degree C only. Storage in frost-free freezers is not recommended. This product should be stored undiluted.
Shelf Life: 12 months from date of reconstitution.
Shelf Life: 12 months from date of reconstitution.
Molecular Weight
1665
OMIM
176830
Preparation
Solid phase synthesis
Product Type
Purified Protein
Buffer Solution
Acetate salt
Preservative Stabilizers
See Buffer Solution
Applications Tested/Suitable for POMC peptide
ELISA (EIA)
Other Notes
Small volumes of POMC peptide vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Searchable Terms for POMC purchase
MBS230189 is a peptide targeting POMC. Also known as SYNTHETIC ALPHA MELANOCYTE STIMULATING HORMONE.
Additional Details
NCBI/Uniprot data below describe general gene information for POMC. It may not necessarily be applicable to this product.
NCBI Official Full Name
pro-opiomelanocortin preproprotein
NCBI Official Synonym Full Names
proopiomelanocortin
NCBI Official Symbol
POMC
NCBI Official Synonym Symbols
LPH; MSH; NPP; POC; ACTH; CLIP
UniProt Protein Name
Pro-opiomelanocortin
UniProt Synonym Protein Names
Corticotropin-lipotropinCleaved into the following 11 chains:NPP; Melanotropin gammaAlternative name(s):Gamma-MSH
Protein Family
Beta-endorphin
UniProt Gene Name
POMC
UniProt Synonym Gene Names
POMC; ACTH; CLIP
UniProt Entry Name
COLI_HUMAN
NCBI Protein Information
pro-opiomelanocortin; adrenocorticotropic hormone; adrenocorticotropin; alpha-MSH; alpha-melanocyte-stimulating hormone; beta-LPH; beta-MSH; beta-endorphin; beta-melanocyte-stimulating hormone; corticotropin-like intermediary peptide; corticotropin-lipotropin; gamma-LPH; gamma-MSH; lipotropin beta; lipotropin gamma; melanotropin alpha; melanotropin beta; melanotropin gamma; met-enkephalin; opiomelanocortin prepropeptide; pro-ACTH-endorphin; proopiomelanocortin preproprotein
NCBI Summary for POMC
This gene encodes a polypeptide hormone precursor that undergoes extensive, tissue-specific, post-translational processing via cleavage by subtilisin-like enzymes known as prohormone convertases. There are eight potential cleavage sites within the polypeptide precursor and, depending on tissue type and the available convertases, processing may yield as many as ten biologically active peptides involved in diverse cellular functions. The encoded protein is synthesized mainly in corticotroph cells of the anterior pituitary where four cleavage sites are used; adrenocorticotrophin, essential for normal steroidogenesis and the maintenance of normal adrenal weight, and lipotropin beta are the major end products. In other tissues, including the hypothalamus, placenta, and epithelium, all cleavage sites may be used, giving rise to peptides with roles in pain and energy homeostasis, melanocyte stimulation, and immune modulation. These include several distinct melanotropins, lipotropins, and endorphins that are contained within the adrenocorticotrophin and beta-lipotropin peptides. The antimicrobial melanotropin alpha peptide exhibits antibacterial and antifungal activity. Mutations in this gene have been associated with early onset obesity, adrenal insufficiency, and red hair pigmentation. Alternatively spliced transcript variants encoding the same protein have been described. [provided by RefSeq, Nov 2014]
Show more UniProt Comments for POMC
POMC: ACTH stimulates the adrenal glands to release cortisol. Defects in POMC may be associated with susceptibility to obesity (OBESITY). It is a condition characterized by an increase of body weight beyond the limitation of skeletal and physical requirements, as the result of excessive accumulation of body fat. Defects in POMC are the cause of pro-opiomelanocortinin deficiency (POMCD). Affected individuals present early-onset obesity, adrenal insufficiency and red hair. Belongs to the POMC family.
Protein type: Secreted, signal peptide; Secreted
Chromosomal Location of Human Ortholog: 2p23.3
Cellular Component: extracellular space; peroxisomal matrix; cytoplasm; extracellular region; peroxisome; secretory granule
Molecular Function: type 3 melanocortin receptor binding; G-protein-coupled receptor binding; hormone activity; type 4 melanocortin receptor binding; receptor binding
Biological Process: generation of precursor metabolites and energy; cellular protein metabolic process; cell-cell signaling; neuropeptide signaling pathway; regulation of blood pressure; peptide hormone processing; regulation of appetite; positive regulation of transcription from RNA polymerase II promoter; negative regulation of tumor necrosis factor production; glucose homeostasis; signal transduction; cellular pigmentation
Disease: Obesity; Proopiomelanocortin Deficiency
Show more Protein type: Secreted, signal peptide; Secreted
Chromosomal Location of Human Ortholog: 2p23.3
Cellular Component: extracellular space; peroxisomal matrix; cytoplasm; extracellular region; peroxisome; secretory granule
Molecular Function: type 3 melanocortin receptor binding; G-protein-coupled receptor binding; hormone activity; type 4 melanocortin receptor binding; receptor binding
Biological Process: generation of precursor metabolites and energy; cellular protein metabolic process; cell-cell signaling; neuropeptide signaling pathway; regulation of blood pressure; peptide hormone processing; regulation of appetite; positive regulation of transcription from RNA polymerase II promoter; negative regulation of tumor necrosis factor production; glucose homeostasis; signal transduction; cellular pigmentation
Disease: Obesity; Proopiomelanocortin Deficiency
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with POMC peptide
| Reference Product | PubMed Publications |
|---|---|
| CRH peptide | >2220 publications with POMC and CRH |
| NPY peptide | >799 publications with POMC and NPY |
| MC4R peptide | >352 publications with POMC and MC4R |
| MC1R peptide | >231 publications with POMC and MC1R |
| CYP17A1 peptide | >200 publications with POMC and CYP17A1 |
| MC3R peptide | >150 publications with POMC and MC3R |
| MC2R peptide | >127 publications with POMC and MC2R |
| MC5R peptide | >90 publications with POMC and MC5R |
| OPRM1 peptide | >15 publications with POMC and OPRM1 |
| GIPR peptide | >5 publications with POMC and GIPR |
Pathways associated with POMC peptide
| Products by Pathway | Pathway Diagram |
|---|---|
| Adipocytokine Signaling Pathway antibodies | Adipocytokine Signaling Pathway Diagram |
| Adipocytokine Signaling Pathway antibodies | Adipocytokine Signaling Pathway Diagram |
| Androgen Biosynthesis Pathway antibodies | Androgen Biosynthesis Pathway Diagram |
| Biological Oxidations Pathway antibodies | Biological Oxidations Pathway Diagram |
| Class A/1 (Rhodopsin-like Receptors) Pathway antibodies | Class A/1 (Rhodopsin-like Receptors) Pathway Diagram |
| Corticotropin-releasing Hormone Pathway antibodies | Corticotropin-releasing Hormone Pathway Diagram |
| Cytochrome P450 - Arranged By Substrate Type Pathway antibodies | Cytochrome P450 - Arranged By Substrate Type Pathway Diagram |
| Defective ACTH Causes Obesity And Pro-opiomelanocortinin Deficiency (POMCD) Pathway antibodies | Defective ACTH Causes Obesity And Pro-opiomelanocortinin Deficiency (POMCD) Pathway Diagram |
| Defective CYP11A1 Causes Adrenal Insufficiency, Congenital, With 46,XY Sex Reversal (AICSR) Pathway antibodies | Defective CYP11A1 Causes Adrenal Insufficiency, Congenital, With 46,XY Sex Reversal (AICSR) Pathway Diagram |
| Defective CYP11B1 Causes Adrenal Hyperplasia 4 (AH4) Pathway antibodies | Defective CYP11B1 Causes Adrenal Hyperplasia 4 (AH4) Pathway Diagram |
Diseases associated with POMC peptide
| Disease Name | Pubmed Publications |
|---|---|
| Immune System Diseases Antibodies | >4202 publications with POMC and Immune System Diseases |
| Cushing Syndrome Antibodies | >2895 publications with POMC and Cushing Syndrome |
| Mental Disorders Antibodies | >2669 publications with POMC and Mental Disorders |
| Obesity Antibodies | >1726 publications with POMC and Obesity |
| Infection Antibodies | >1017 publications with POMC and Infection |
| Kidney Diseases Antibodies | >1004 publications with POMC and Kidney Diseases |
| Gastrointestinal Diseases Antibodies | >944 publications with POMC and Gastrointestinal Diseases |
| Diabetes Mellitus Antibodies | >850 publications with POMC and Diabetes Mellitus |
| Necrosis Antibodies | >675 publications with POMC and Necrosis |
| Hemorrhage Antibodies | >670 publications with POMC and Hemorrhage |
Organs/Tissues associated with POMC peptide
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Brain Antibodies | >18468 publications with POMC and Brain |
| Pituitary Gland Antibodies | >9008 publications with POMC and Pituitary Gland |
| Lung Antibodies | >989 publications with POMC and Lung |
| Eye Antibodies | >617 publications with POMC and Eye |
| Testis Antibodies | >554 publications with POMC and Testis |
| Intestine Antibodies | >434 publications with POMC and Intestine |
| Embryonic Tissue Antibodies | >392 publications with POMC and Embryonic Tissue |
| Placenta Antibodies | >367 publications with POMC and Placenta |
| Uterus Antibodies | >239 publications with POMC and Uterus |
| Uncharacterized Tissue Antibodies | >2 publications with POMC and Uncharacterized Tissue |


